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INTRODUCTION 
Vitreous hemorrhage is defined as the presence of extravasated 
blood in the vitreous cavity. The source of the blood may be due to 
various etiology and pathologic mechanism. The anatomical, 
physiological and biochemical properties of the vitreous affects the blood 
catabolism in a different way from other tissues so the vitreous 
hemorrhage differs from other tissues of the body. 
Hence it is appropriate to discuss the text in the following format 
prior to the discussion of the vitreous hemorrhage: 
• Anatomy of the vitreous cavity 
• Physiology of the vitreous 
• Morphology and composition of the vitreous 
• Physiochemical properties  of the vitreous 
ANATOMY OF THE VITREOUS CAVITY 
The vitreous cavity is bounded anteriorly by the lens and the ciliary 
body. Posteriorly by the retina. Its volume is 4cc about 2/3 volume of the 
globe. It is a gel like substance made up of 99% of water. Vitreous base 
extends 2mm anteriorly to pars plana and 4mm posterior to ora serrata. 
The outer or the cortical layer of the vitreous contains a small number of 
cells termed as halocytes. The concentration of the halocytes is more 
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around the vitreous base. They have the phagocytic activity and produce 
hyaluronic acid. 
A delicate meshwork of collagen fiber is present along with the 
hyaluronic acid and gives the vitreous its rigidity and viscosity. This 
collagen meshwork is less dense in the centre than in the periphery. It is 
most dense at the vitreous base. The strongest attachment is at the pars 
plana and the retina periphery. The vitreous is firmly attached to the peri 
papillary region and less firmly to the posterior surface of the lens and the 
macula. This is called hyaloidcapsular ligament of weigert.  
The vitreous around the blood vessels is irregularly arranged. The 
anterior hyaloid membrane is formed by the anterior condensation of the 
peripheral vitreous .the vitreous condensation posterior to the vitreous 
base produces the posterior hyaloid membrane. The vitreous fibrils are 
arranged parallel to the retina elsewhere except at the vitreous base where 
it is attached perpendicular to the retinal surface. 
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VITREOUS ATTACHMENTS 
1. Optic Disc 
2. Fovea 
3. Retinal Vessels 
4. Vitreous Base 
EMBRYOLOGY 
During the first month of gestation the primary vitreous contains 
the mesodermally derived hyaloid vascular system and the ectodermally 
derived fibrillar  meshwork present between the lens and the retina.  
By the second month of gestation the collagen and the hyaluronic 
acid develops forming the secondary vitreous called the adult vitreous. 
The vitreous cavity starts filling by secondary vitreous the 14th week of 
gestation and gets completed by 7th month of gestation. The cloquet’s 
canal which is nothing but the remnant of the primary vitreous extends 
from the posterior surface of the lens to the optic disc in a S shaped 
pattern. 
VITREOUS BARRIERS 
Vitreoretinal barrier is the term used describe that the vitreous 
constituents cannot equilibriate with the blood and with surrounding 
fluids. The mechanism involved are 
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1. Tight junctional complexes inhibiting the transport of high 
molecular weight components at the level of non pigment 
epithelium of ciliary body, pigment epithelium of retina and the 
retinal vascular endothelium. 
2. At the above sites the active transport also plays the role. 
3.  Physical blockage of large molecules at the basal lamina of the 
vitreoretinal junction. 
4. The collagen fibrillary network has a specific physiochemical 
property which also plays a major role in the transport to 
effectively block or retard the movement of the cells. 
PHYSIOLOGY OF THE VITREOUS  
The vitreous provides an optically negative space occupying the 
posterior 2/3 of the globe for the light rays to travel to the retina focused 
by the cornea and the lens. 
The hyalocytes and the fibrocytes are specific cellular element 
present in the cortical layer lying in the collagen network. The major 
morphological development is over before the birth but the biochemical 
properties are gained till reaching the adulthood. The vitreous differs 
from aqeous by its physical and biochemical properties. 
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MORPHOLOGY AND COMPOSTION 
The vitreous is almost a fully hydrated gel with 95% of water 
content. It consists of cortical layer of cells and collagen. The hyalocytes 
are concentrated more in the narrow zone adjacent to the retina and the 
ciliary body. The fibrocytes are located next to the optic disc. These cells 
are the centre for the metabolism. The hyalocytes have a phagocytic 
function and are the source of extracellular hyaluronic acid.The 
components of vitreous body is divided into 
1. Macromolecular constituents  
2.  Low macromolecular constituents. 
Macromolecular constituents 
The various macromolecular constituents are: 
A. Collagen 
It is an insoluble protein obtained from the vitreous by high speed 
centrifugation or by filtration. It is present more near the vitreous base 
and in the cortical areas adjacent to the retina. 
It has certain specific features of typical collagen 
1. It is soluble in boiling water. 
2. May be hydrolysed to form gel 
3. Can be degraded by collagenase. 
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4. Has typical x-ray diffraction pattern. 
It has certain atypical features like 
1. Those insoluble collagen fibrils are thinner. 
2. They do not show the usual banding pattern of collagen. 
3. Its has a slightly higher glycoprotein and nitrogen content. 
4. Can be degraded by proteolytic enzymes. 
B. Soluble proteins  
The soluble proteins are disproportionate amount of acidic 
glycoproteins ,when compared to aqueous or serum. Its concentration is 
more in the cortical area adjacent to the retina. 
C. Hyaluronic acid 
It is also known as glycos aminoglycans. It is a linearly arranged 
polymer consisting of glucoronic acid and N-acetyl glycosamine. The 
hyaluronic acid is a negatively charged molecule and its coils upon itself. 
It produces a large sponge like spheroidal configuration that can bind 
more than fifty times its weight in water. 
Low molecular weight components 
The concentration of the various component is similar to that of 
aqueous or serum with minor differences, which are due to the various 
metabolic or transport activities of the vitreous and other ocular tissues. 
 7 
A. Water 
The turnover of vitreous water is extremely high, half of that 
present is replaced every 10 to 15 minutes. 
B. Sodium 
As sodium is distributed passively , its concentration in vitreous is 
same as that of other intraocular extracellular fluids. 
C. Potassium 
The active transport of potassium from the anterior surface of the 
lens and passive diffusion from the posterior surface into the vitreous 
leads to the increased potassium concentration in the vitreous. 
D. Bicarbonate 
Due to the active metabolism of the surrounding tissues its level is 
low. 
E. Glucose 
It diffuses from the ciliary body and the retina into the vitreous 
cavity. 
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F. Amino acid 
Except glutamic acid all other amino acids are at lower 
concentration this is because of the uptake and usage by the cortical 
hyalocytes. 
G. Ascorbic acid 
It is much higher concentration in the vitreous than in the blood 
due to the active transport of ascorbic acid by ciliary epithelium from the 
blood. with copper and oxygen it forms a polymerization system that 
plays a role in vitreous hyaluronic acid turnover. 
PHYSICOCHEMICAL PROPERTIES 
They are responsible for the following properties 
1. Rigidity, viscosity and elasticity of the vitreous gel. 
2. vitreous transparency 
3. volume change properties 
4. vitreous cell distribution in the cortical layers. 
The physicochemical properties are 
• Frictional interaction  
The dual network consisting of collagen fibres and hyaluronic acid 
filling the spaces between the fibres forms a stable system that can resist 
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disorganizing forces like centrifugation. The ineraction between the two 
provides the stable structure. 
• Vitreous expansion and contraction 
Normal vitreous contains sodium ions and sodium chloride 
molecules that interlies the negatively charged hyaluronic acid. If 
positively charged molecules introduced the gel will contract and 
collapse. 
If sodium chloride molecules removed the entire gel will expand 
because the hyaluronic acid molecules are free to repel one another. 
• Excluded volume concept 
The vitreous is able to restrict the diffusion of cellular element 
because of the collagen fibrils and large sized hyaluronic acid. 
• Molecular sieve effect 
The cortical vitreous can even retard the flow of low molecular 
weight component the positively charged molecule are trapped by the 
electrostatic field of poly anionic chains of hyaluronic acid. 
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VITREOUS HEMORRHAGE 
Historical review 
Helmholtz invent the ophthalmoscope in 1850 but it was not used 
for many years Gullstrand invent the first crude version of slit lamp in 
1910 until early part of century the studies about vitreous hemorrhage 
were done with little clinical correlation. 
The first experimental study of vitreous hemorrhage were 
performed more than 100 years ago by Probsting and Von hippel. Those 
authors described findings after injection of blood into the vitreous of 
rabbits. Sub choroidal hemorrhage, one of the earliest conditions reported 
to associated with vitreous hemorrhage ,was first described by Litten in 
1881 and named after Terson in 1900. 
Before the advent of vitrectomy there were no treatment for non 
resolving vitreous hemorrhage. In 1967, Duke Elder described that 
proliferative diabetic retinopathy and vitreous hemorrhage are untreatable 
and not preventable. 
This dramatically changed with the introduction of xenon and 
argon laser photocoagulation. In 1962 Kasner, used open sky vitrectomy. 
Machemer performed first human pars plana vitrectomy on april 20,1970. 
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Vitreous Humour Anatomy 
DEFINITION 
Vitreous hemorrhage is defined as the presence of extravasated 
blood within the space outlined by internal limiting membrane of retina 
posteriorly and laterally, Non pigmented epithelium of ciliary body 
laterally and the lens zonular fibres and posterior lens capsule anteriorly. 
   
 12 
Site: 
1. within formed vitreous 
2. Bergers space [retrolental space of Erggelet] 
3. Canal of petit 
4. Cloquets canal 
5. Bursapremacularis 
6. Retro hyaloid or sub hyaloid space 
INCIDENCE 
7 cases/lakh population each year. 
ETIOLOGY 
1. Proliferative diabetic retinopathy 
2. Ocular trauma 
3. Eales disease 
4. Vitreous detachment with or without retinal tear, retinal 
detachment 
5. Vitreous hemorrhage secondary to retinal vein occlusion. 
6. Proliferative sickle cell retinopathy 
7. Retinalmacroaneurysm 
8. Age related macular degeneration 
9. Subarachnoid hemorrhage  
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Inflammatory causes 
1. Bechets disease 
2. Retinal vasculitis 
3. Parsplanitis 
4. Syphilitic retinitis 
5. Systemic lupus erythematosus 
Vascular causes 
1. Coats disease 
2. Retinal vein rupture 
3. Hypertensive retinopathy 
4. Venous stasis retinopathy 
5. Sarcoid posterior uveitis 
6. Retinopathy of prematurity 
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Blunt Trauma with Vitreous Haemorrhage 
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Penetrating injury with Vitreous Haemorrhage 
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Blood disorder 
1. Anemia 
2. Thrombocytopenia 
3. Idiopathic thrombocytopenic purpura 
4. Thrombotic thrombocytopenic purpura 
5. Disseminated intravascular coagulation 
6. Hemophilia 
7. Leukemia 
8. Anti coagulant therapy 
Tumor 
1. Choroidal malignant melanoma 
2. Retinoblastoma 
3. Cavernous hemangioma of optic disc 
4. Retinalangioma 
Other causes 
1. adverse effect of retinal laser photocoagulation . 
2. After cataract surgery 
3. After trabeculectomy 
4. After secondary iol implantation, posterior chamber implantation 
5. Penetrating keratoplasty 
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6. Bulbous perforation during retrobulbar, peribulbar injections 
surgeries 
7. Alteration of iris vessels by prolapsed pciol 
8. pseudo tumour cerebri 
9. Valsalva retinopathy 
10. chest compression 
11. physical exertion 
12. Retinitis pigmentosa 
13. Tearing of retinal pigment epithelium 
14. Topical pilocarpine therapy 
CLINICAL FEATURES 
Symptoms 
1. Visual haze 
2. Floaters 
3. Smoke signals  
4. Photophobia 
5. Perception of shadows 
6. Flashes of light 
7.  Defective/loss of vision 
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Signs 
Visual Acuity 
Visual acuity is determined by the location and density of the 
hemorrhage. 
Ophthalmic examination 
Blood is found within vitreous gel/anterior hyaloid retrohyaloid 
space. 
Blood within berger’s space settles down and forms crescent 
shaped pool with hyaloideo capsular ligament since inferior border. 
Hemorrhage into canal of petit has crescent shaped superior border. 
Blood in cloquet’s canal outline  its inferior border. Blood in retrohyaloid 
space collect as meniscus at inferior retrohyaloid. Intravitreal hemorrhage 
shows no characteristic border and rapidly clots.  
B SCAN 
Determination of location and density of vitreous hemorrhage , 
location and extent of traction membrane and retinal detachment and 
virtreo retinal relationship. 
CT SCAN AND MRI 
Hemorrhages in other location such as brain to vitreous. 
Pathological mechanism 
 19 
Bleeding from diseased retinal vessels/abnormal new vessels: 
Retinal ischemia results in new vessels by production of angio 
genic factors. 
• Proliferative diabetic retinopathy 
• Proliferative sickle cell retinopathy 
• Retinopathy of prematurity 
• Rupture of normal retinal vessels: 
• Retinal break or posterior vitreous detachment as in case of trauma. 
• Extension of hemorrhage through retina from other sources.  
• Subretinal bleeding with secondary break through into vitreous 
cavity as in ARMD and choroidal melanoma. 
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B-Scan Ultrasonography Shows Dense Vitreous haemorrhage 
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PATHOPHYSIOLOGY OF BLOOD CATABOLISM IN 
VITREOUS: 
It differs from hemorrhage into other tissue outside eye. 
• Rapid clot formation with short borders  
• Slow lysis of fibrin. 
• Extracellular lysis of red blood cells. 
• Persistence of intact red blood cells for months 
• Lack of early PMN response 
 
RAPID CLOT FORMATION: 
Bleeding into vitreous gel results in rapid formation of clot with 
short borders although tissue thromboplastin activity is low. 
Vitreous collagen facilitates platelet aggregation and enhancement 
of clotting via intrinsic clotting process and membrane formation. 
Passive diffusion of red cells and fibrin is inhibited because of 
lattice work of vitreous collagen fibres with large hyaluronic acid 
molecules with large hyaluronic acid molecules in inter spaces. 
Thromboplastin activity in vitreous is 5.5*,fibrinolytic activity in 
vitreous is 0” 
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SLOW LYSIS OF FIBRIN 
Lysis of fibrin in formed vitreous is very slow because of low level 
of vitreal tissue fibrinolytic activity on lack of pmn response. 
EXTRACELLULAR LYSIS OF RED BLOOD CELL: 
Erythrocytes in vitreous undergo hemolysis either by extracellular 
release of lysosomal enzymes by macrophages or auto hemolysis. 
PERSISTANCE OF INTACT RED BLODD CELLS FOR 
MONTHS: 
Red cells possess metabolic requirements to adjust special 
conditions in vitreous and fail to elicit macrophage reaction. 
LACK OF EARLY POLYMORPHONUCLEAR LEUCOCYTE  
RESPONSE: 
This results in persistence of fibrin this in turn leads to lack of 
fibrin degradation products a stimulator of PMN. This cellular response 
leads to phagocytosis of erythrocytic debris than whole erythrocytes.  
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NATURAL COURSE OF VITREOUS HEMORRHAGE: 
Depends on the site of vitreous hemorrhage. 
1. hemorrhages into spaces outside the formed vitreous: 
It gets absorbed readily in cases of sub or retro hyaloid hemorrhage 
resorption of hemorrhage leaves only few deposits of fibrin on posterior 
surface of detached vitreous this is described assilk like veils. 
2. Hemorrhage into the formed vitreous gel: 
It clears very slowly with time constant 1percent per day. Intra 
vitreal hemorrhage is followed by rapid clotting mediated by contact of 
platelets with intra vitreal collagen with slow fibrinolysis.  
Fibrinolysis of clotted blood diffusion of erythrocytes out of blood 
clot, extracellular hemolysis limits resorbtion of vitreous hemorrhage. 
clotted blood in vitreous gel remains in lamellar fashion until vitreous 
liquefies and the blood sinks to bottom of vitreous cavity where it is 
absorbed. Accumulation of red blood cells and red cell debris suspended 
in and mixed with vitreous collagen can present as ‘ochre membrane’. 
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Iindirect ophthalmoscope showing dense vitreous haemorrhage 
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SYNCHISIS SCINTILLANS: 
Muticoloured glittering particles settles in lower part of vitreous 
cavity due to gravity but can be thrown up by eye movements to form 
shower of iridescence this occurs in long standing vitreous hemorrhage. It 
represents cholesterol crystals as a result of break down of red blood 
cells. 
VITTREOUS CYLINDERS 
It is secondary to vitreous hemorrhage. Tubular structures develop 
from detached vitreous lamella that condenses to form cylinder structures. 
PROGNOSIS: 
It depends on site, density, recurrence of vitreous hemorrhage 
1. avulsion of vessel associated retinal tear or posterior vitreous 
detachment  has good prognosis since there is no tendency of 
recurrent bleeding. 
2.  Proliferative diabetic retinopathy has worst prognosis due to 
recurrent/persistent vitreous hemorrhage. 
3. Retinal vein occlusion. 
Central vein occlusion has worst prognosis 
Branch retinal vein occlusion has best prognosis. 
Hemi retinal vein occlusion has prognosis in between two 
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4. Proliferative sickle cell retinopathy shows better prognosis as it 
affects peripheral vessels of retina. 
5. vitreous hemorrhage secondary to ARMD has poor prognosis. 
VITREOUS HEMORRHAGE IN BLUNT TRAUMA 
BLUNT TRAUMA: 
The objects causing the blunt trauma do not  penetrate the eye but 
cause rupture of the eye wall. It can have number of sequelae : 
1. angle recession 
2. hemorrhege into the anterior chamber or the vitreous 
3. retinal tears or the detachment 
4. subluxated or the dislocated lens 
5. commotio retinae 
6. choroidal rupture 
7. macular hole 
8. avulsed optic nerve 
9. scleral rupture 
A complete ophthalmic examination is required for a blunt trauma 
because an eye without hyphaema or iritis can have a retinal tear or 
choroidal rupture  or blowout fracture. 
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Choroidal Detachment Following Blunt Trauma 
 
 
Slit lamp examination shows yellowish Hue in case of Vitreous 
Haemorrhage 
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VITREOUS HEMORRHAGE  
Vitreous hemorrhage results from the damage to the blood vessels 
of iris, ciliary body ,retina ,choroid. A search for the cause of the 
hemorrhage should be undertaken as sometimes a hemorrhage which is 
located at time of presentation can become diffuse later. So an initial 
thorough IDO examination is required. If posterior segment could not be 
seen because of vitreous hemorrhage ultrasound examination is 
necessary. Retinal or choroidal detachment or tear and posterior vitreous 
detachment can be identified. Echographic  sign of occult scleral rupture 
include vitreous strands that feed into the rupture site. 
More often bed rest with elevation of patients head is sufficient to 
allow the blood to settle down for detailed ophthalmoscopic examination. 
If the source of the hemorrhage is still not identified regular follow up 
with ultrasound examination is indicated until the hemorrhage clears. 
Macular hole, choroidal rupture, traumatic maculopathy, retinal 
detachment or their injuries can limit the visual outcome. 
COMMOTIO RETINAE: 
The term commotion retinae refers to damage to the outer retinal 
layers caused by the shock waves that traverse from the site of impact 
following blunt trauma. Ophthalmoscopic examination reveals the sheen 
like retinal whitening that appears some hours after the injury. The retinal 
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whitening is mostly found in the posterior pole but also in the periphery 
as well. Mechanism for retinal opacification includes extracellular edema, 
glial swelling and photoreceptor disruption. With involvement of the 
fovea cherry red spot appears as the cells involved in the whitening are 
not present in the foveola. 
Commotio retinae in the posterior pole is called the berlins edema 
that may reduce the visual acuity to as low as 20/200. The prognosis of 
the vision is good as the condition clears in 3-4weeks.in some cases 
visual prognosis is limited by the presence of macular pigment 
epitheliopathy, choroidal rupture or macular hole formation. No effective 
treatment is known. 
COMPLICATIONS: 
1. siderosis bulbi and retinal damage 
sub retinal hemorrhage irreversibly damage photoreceptor cells this 
leads to cell lysis with release of iron and hemoglobin leading to retinal 
degeneration. 
2. Proliferative retinopathy: 
It is caused by phagocyte mediated stimulation of retinal glial cells 
vascular endothelial cells and retinal pigment epithelial cells. Once pre 
retinal proliferation are established recurrent bleeding may cause vitreous 
 30 
collapse with traction on newly formed vessels and subsequent recurrent 
hemorrhage. 
3. Glaucoma: 
It is rare complication. 
A. Ghost cell glaucoma: 
Following vitreous hemorrhage fresh RBCs degenerate into ghost 
cell within one to three weeks and obstruct trabecular meshwork causing 
secondary open glaucoma. 
B. Hemosiderotic glaucoama 
hemosiderotic glaucoama is a late onset glaucoma following  a 
trauma that causes intraocular hemorrhage with iron  deposition and 
damage to the trabecular meshwork. This is an extremely rare glaucoma 
and is chronic, does not have ghost cells in the anterior chamber. Usually 
occurs many years following trauma. In contrast to the ghost cell 
glaucoma which occurs within months or weeks following trauma. 
C. Hemolytic glaucoma 
Hemolytic glaucoma is a type of secondary glaucoma occurs 
following vitreous hemorrhage due to the obstruction of the trabecular 
mesh work by red blood cell debris and the macrophages. 
  
 31 
MANAGEMENT 
Principles of management: 
1. To arrest bleeding from vessels 
2. To accelerate absorption of formed blood 
3. In non clearing vitreous hemorrhage surgical intervention 
TYPES 
1. Conservative 
2. Surgical 
CONSERVATIVE MANAGEMENT: 
In case of retro hyaloid hemorrhage blood resorption occurs 
rapidly. Normally if eye movements are restricted blood in space 
gravitates to bottom and collects as meniscus at inferior vitreoretinal 
demarcation hence management includes binocular patching an position 
the patient vertically. 
PHOTOCOAGULATION  
Principle is to arrest the bleeding and prevent the recurrence. It is 
indicated in proliferative diabetic retinopathy,BRVO, sickle cell 
retinopathy. 
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CRYOTHERAPY: 
In cryotherapy there is break down of blood retinal barrier followed 
by increasing passage of plasminogen activators from choroid and retina 
.this causes blood clot lysis and resorption. It is indicated only when pars 
plana vitrectomy is not  available in non resolving vitreous hemorrhage. 
POSTERIOR HYALOIDOTOMY: 
In case of hemorrhage located between internal limiting membrane 
and retina posterior hyaloidotomy using nd-yag laser disrupt internal 
limiting membrane and release blood in vitreous cavity this prevents 
macular degeneration. 
3 Port Pars Plana Vitrectomy 
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SURGICAL MAMNAGEMENT: 
Pars plana vitrectomy 
Pars plana vitrectomy is a vitreo retinal surgical technique typically 
used for removing the vitreous opacities, removing the vitreo retinal 
traction and restoring the normal anatomical relationship between 
vitreous and retina. It requires the placement of 3 ports at 3-4mm from 
the surgical limbus. One port is made for the infusion of balanced 
solution to maintain the required intraocular pressure. Other port is for 
endo illumination to view the posterior segment. Other port is for 
manipulate, dissect or remove intraocular objects ,ocular tissues, fluids. 
Vitrectomy is performed with an operating microscope using 
contact or non contact lenses. Direct and indirect visualization is possible. 
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In indirect visualization there is advantage of wider angle visualization 
,better view through medium opacities, miotic pupil. The direct 
visualization provides better stereopsis and enhanced magnification at 
expense of smaller field. 
Advanced instrumentation includes high speed cutters, endo laser 
probe, micro-pic, retinalscissors, fragmentome. Visualization aids 
includes indocyanin green for viewing internal limiting membrane and 
triamcinolone suspension for identifying the cortical vitreous. Tamponade 
of the retina is achieved using  air, gas, silicone oil as substitutes. 
Commonly used gases includes sulfur hexafluoride[S3F6] and 
perflouropropane[C3F8].  
They have a half life of 1-3weeks at an isovolumetric 
concentration. Perfluorocarbon liquids are heavier than water and can be 
used for temporary stabilization of retina during the dissection and 
draining of fluid from subretinal space for repair of retinal detachment. 
A more recent advance is the development of smaller gauge trans 
conjunctival technique vitrectomy technique. Uses the 23,25 gauge 
instead  of older 20 gauge sclerotomy. Entry cites into the vitreous cavity  
is made using 23 or 25 gauge so that suturing can be avoided and avoids 
the conjunctival cut down procedure and the need for cautery. Potential 
advantages are the shortened operative time, better post operative comfort 
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and faster visual recovery. But there are disadvantages including 
postoperative hypotony, endophthalmitis and retinal tears. 
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`  
INDICATIONS OF VITRECTOMY FOR VITREOUS 
HEMORRHAGE: 
Vitrectomy is indicated after 6weeks to 3months of failure of 
spontaneous clearance of vitreous hemorrhage.  Possible indications for 
prompt intervention is the bilateral  hemorrhage , associated retinal tear 
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and retinal detachment. During the interval period of observation  serial 
ultrasonography is done to monitor anatomical condition of retina in case 
of absence of retinal visualization. If surgery is indicated it involves 
removal of vitreous hemorrhage, and release of hyaloid from fronds of 
retinal neovascular ingrowth. 
COMPLICATIONS OF PARS PLANA VIRECTOMY 
1. long term risk of open angle glaucoma 
2. intra operative or post operative retinal break 
3. intraoperative or postoperative retinal detachment 
4. intraoperative cataract 
5. postoperative vitreous hemorrhage 
6. postoperative massive fibrin exudation 
7. postoperative anterior segment neo vascularization. 
8. post operative nuclear sclerotic cataract. 
COMPLICATIONS ASSOCIATED WITH SILICONE OIL: 
• Glaucoma  
• Band keratopathy 
GENERAL COMPLICATIONS: 
• Endophthalmitis. 
• Sympathetic ophthalmia. 
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• Recurrent erosions. 
Other indications: eales disease, bechets disease, uveitis, retinal 
tears, leukemia, trauma. 
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AIM OF THE STUDY  
To analyse various etiological incidence of vireous hemorrhage. 
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MATERIALS AND METHODS 
Prospective study was carried out on 176 patients diagnosed 
vitreous hemorrhage irrespective of the age, sex after history taking 
routine clinical examination direct ophthalmoscopy,  indirect 
ophthalmoscopy,  slit lamp bio microscopy, A scan, B scan, clinical 
findings of other eye, systemic evaluation and laboratory investigations. 
History taking includes history of symptoms like flashes of light, 
smoke signal, photophobia, perception of shadows and cob webs , visual 
haze , defective vision ans loss of vision etc. 
History of trauma 
History of ocular disorders like proliferative retinopathy, 
inflammatory occlusive retinal vascular disorders, retinal tear, posterior 
vitreous detachment etc. 
History of infections 
History if systemic illness like diabetes mellitus , hypertension, 
blood disorder, connective tissue disorder. 
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• History of ocular tumours 
• History of surgical procedures  
CLINICAL EXAMINATION 
Anterior segment examination by oblique illumination and slit 
lamp examination. 
Visual acuity is determined by the location and density of vitreous 
hemorrhage. 
Tension is raised in ghost cell hemolytic and hemosiderrotic 
glaucoma. fundus examination by direct ophthalmoscopy, indirect 
ophthalmoscopy , slit lamp bio microscopy  includes three mirror 
examination with + 90D LENS 
Fundus fluorescein angiography- vascular status of choroid and 
retina. 
A scan and B scan ultra sonography determines the location and 
density of vitreous hemorrhage and extent of tractional membranes  and 
retinal detachment which predict visual outcome after vitreous surgery. 
   
 42 
General and systemic evaluation 
To rule out hypertension diabetes and infective disease like 
tuberculosis, syphilis, connective tissue disorder etc.  
Laboratory investigations include peripheral smear, blood sugar, 
serum cholesterol, serum proteins, VDRL, mantoux , anti nuclear 
antibodies , rheumatoid factors . 
X RAY skull , CT scan, MRI to rule out increased intra cranial 
tension, hemorrhages. 
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RESULTS 
The results of the study conducted at RIOGOH during the period 
from Feb’17 to Sept’17. 
The incidence of the various etiology of vitreous hemorrhage 
Total number of cases 100 
Age incidence between 10 to 70 years 
Sex incidence Male – 67 Female – 33 
DIAGNOSIS 
AGE 
(YRS) 
SEX 
M       F
LATERALITY
UNI      BI 
WITHOUT 
PVD 
WITH
PVD 
RT RD TOTAL % 
PDR 35 – 70 26     9 22       13 8 21 - 6 35 35 
OCULAR 
TRAUMA 22 – 52 16    10 26         0 10 16 5 5 26 26 
EALE’S DISEASE 22 – 58 8        3 6         5 8 3 - - 11 11 
SPONTANEOUS 
PVD 62 – 70 7       1 8         0 - 3 4 1 8 8 
RETINAL VEIN 
OCCLUSION 45 – 63 3        1 4         0 3 1 - - 4 4 
PARS PLANITIS 34 – 46 1        1 2          0 2 - - - 2 2 
RETINAL 
VASCULITIS 44 – 58 0       2 2          0 2 - - - 2 2 
SENILE PVD 44 – 78 1        1 2          0 0 2 - - 2 2 
POST OP 
COMPLICATION
(ECCE/PCIOL) 
65 – 68 1        1 2          0 2 - - - 2 2 
UNKNOWN 23 – 54 3        5 8          0 8 - - - 8 8 
 
PDR- Proliferative diabetic retinopathy 
PVD –Posterior vitreous detachment 
RT –Retinal tear 
RD- Retinal detachment  
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ANALYSIS  
Causes of vitreous hemorrhage in different studies ANALYSIS 
AND DISCUSSION 
CAUSES OF VITROUS HEMORRHAGE IN DIFFERENT 
STUDIES 
AUTHOR AND 
REFERENCE 
Winslow and 
Taylor 
Butner and 
Mecpherson Dana et al 
Lindgrend et 
al RIOGOH 
Year 1980 1982 1993 1995 2017 
Mean age(years) N.A 49 48 65 50 
Region DALLAS LAS VEGAS ILLIONOIS SWEDEN CHENNAI 
Patients 100 653 198 94 100 
DIAGNOSIS      
PDR 31.5% 34.1% 34.7% 19.1% 35 
TRAUMA - - 18.8% - 26 
EALES DISEASE - - - - 
11 
 
RVO 12% 13.0% 7.9% 16.0% 4 
OTHERS  6.9% 7.2% 8.9% 6.4% 14 
UNKNOWN 7.6% 2.1% 2.0% 4.3% 8 
The above previous six studies show proliferative diabetic 
retinopathy, spontaneous posterior vitreous detachment with or without 
retinal tear,with retinal detachment or without retinal detachment and 
ocular trauma are the three most common causes of vitreous hemorrhage 
and accounts for  59.8% to 88.9% of all causes.  
The study conducted at RIOGOH ,Chennai during the period from 
February 2017 to September 2017 revealed proliferative diabetic 
retinopathy, ocular trauma, Eale’s disease and senile posterior vitreous 
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The five most common causes of vitreous hemorrhage are 
1. Proliferative diabetic retinopathy 
It is the most common cause of vitreous hemorrhage accounts for 
35%(35 out of 100 )the age incidence varying between 35 years to 70 
years. Among them type 1 diabetes mellitus accounts for 20%(7 out of 35 
cases) and remaining 80%(28 out of 35cases ) accounts for type 2 
diabetes mellitus,62% ( 22 out of 35 cases ) of patients presented with 
unilateral incidence and 38% ( 13 out of 35 cases ) of patients presented 
with bilateral incidence. 
The study shows incidence of vitreous hemorrhage in proliferative 
diabetic retinopathy, associated with other ocular pathology are as 
follows 
Vitreous hemorrhage without PVD 22% (8 out of 35 cases) 
Vitreous hemorrhage with PVD 60%( 21 out of 35 cases) 
Vitreous hemorrhage with RD 18%( 6 out of 35 cases) 
The proliferative diabetic retinopathy was the most common cause 
of vitreous hemorrhage in two to six available retrospective 
epidemiologic studies (Morse et al in the year 1974 at Philadelphia(200), 
Winslow and Taylor in the year 1980 at Dallas(100 cases), Lean and 
Gregor in the year 1980 at London (317cases) , Butner and Mecpherson 
in the year 1982 at Lasvegas, (653 cases),Dana et al in the year 1993 at 
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Illinois (198 cases),Lingrend et al in the year 1995 at Sweden (94 cases) 
of the patients witth incidence of vitreous hemorrhage, mean age varying 
between 48-65years and accounts for 32%of cases. Among them patients 
with type 1 diabetes mellitus accounts for  89% and type 2 diabetes 
mellitus accounts for64%. 
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Proliferative Diabetic Retinopathy with Post Panretinal 
Photocoagulation 
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Proliferative Diabetic Retinopathy 
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2. Ocular trauma: 
It is the second most common cause of vitreous hemorrhage 
accounts for 26%(26 out of 100 cases ) of all cases, the age incidence 
varying between 22-52years, sex incidence of male 65%(16 out of 26 
cases ), female-  35%(10 out of 26 cases ). The incidence of various types 
of ocular trauma associated with vitreous hemorrhage are as follows: 
Blunt injury 69%(18 out of 26 cases) 
Penetrating injury 27%( 7 out of 26 cases) 
Perforating injury 4%( 1 out of 26 cases) 
The study shows the incidence of hemorrhage in ocular trauma 
with vitreous associated ocular pathology are as follows: 
TYPE OF OCULAR 
INJURY 
WITHOUT 
PVD 
WITH 
PVD 
RETINAL TEAR 
RETINAL 
DETACHMENT 
WITH 
PVD 
WITHOUT 
PVD 
WITH 
PVD 
WITHOUT 
PVD 
BLUNT INJURY (18) 2 9 5 0 2 0 
PENETRATING 
INJURY(7) 0 0 3 1 2 1 
PEFORATING 
INJURY (1) 0 0 1 0 0 0 
 
The incidence of ocular trauma in vitreous hemorrhage was 
included in two series (Lean and Gregor in the year 1980 at London(12% 
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out of 317cases). Dana et al in the year 1993 at Illinois (18.8% of 198 
cases) of six available retrospective studies and represented the second 
most common cause of vitreous hemorrhage, wuth age incidence of under 
40 years and male showed higher incidence than female. 
Blunt Trauma 
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3. Eale’s disease 
It is the most common cause of vitreous hemorrhage accounts for 
11% of all cases, the age incidence between 22-58 years. 73%(8 out of 11 
cases ) are males and 27%(3 out of 11 cases) are females, 55%(6 out of 
11 cases ) of patients presented with unilateral incidence and 45%( 5 out 
of 11 cases )of patients presented with bilateral incidence. 
The incidence of vitreous hemorrhage in Eale’s disease associated 
with other ocular pathology are as follows 
Vitreous hemorrhage without PVD 73%( 8 out of 11 cases ) 
Vitreous hemorrhage with PVD 27%(3 out of 11 cases ) 
The previous available six retrospective studies (Morse et al in the 
year 1974 at Philadelphia(200 cases), Winslow and Taylor in the year 
1980 at Dallas(100cases), Lean and Gregor in the year 1980 at 
London(317 cases), Butner and Mecpherson in the year 1982 at 
Lasvegas,(653 cases), dana et al in the year 1993 at Illinois (198cases), 
Lindgrend et al in the year 1995 at Sweden(94 cases) if incidence of 
vitreous hemorrhage showed no incidence of Eale’s disease as a cause of 
vitreous hemorrhage. The previus six studies conducted in western 
countries where the incidence of Eale’s disease is very low. 
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Eale’s disease(Eale’s disease by Tara Prasad Das, Jyothirmay 
Biswas, Atul Kumar, P.N.Nagpal, P.A.Namperumal samy,Bijayanandha 
Patnaik and H.K.Tewari, I J O volume 42 no.1 March 1994) has been 
reported from the united kingodom, the United States, and Canada in later 
half of 19th and early 20th century. But for unknown reasons, it is now rare 
in more developed countries and is more commonly reported from the 
Indian sib continent. The reported incidence in India is 1 in 200 to 250 
ophthalmic patients. Eventually between the peak age of incidence 
between 20 to 30years, between 70 to 80 years of patients develop 
bilateral involvement though the extent of retinal in volvement may not 
be to the same extent. 
Duke elder noted 90% bilateral involvement and others have noted 
only 50% of  involvement. 
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Eales Disease 
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4. Spontaneous posterior vitreous detachment: 
It is the fourth most common cause of vitreous hemorrhage 
accounts for 8%( 8 out of 100 cases ). The age of incidence varying 
between 62 years to 70 years. 88% (7 out of 8 cases) are found to be 
males and 12%(1 out of 8 cases )are found to be females. The incidence 
of vitreous hemorrhage in spontaneous  PVD associated with other 
pathology are as follows 
Vitreous hemorrhage with PVD 38% ( 3 out of 8 cases) 
Vitreous hemorrhage with retinal tear 50%( 4 out of 8 cases ) 
Vitreous hemorrhage with RD 12%( 1 out of 8cases) 
The previous available six retrospective studies(Morse et al in the 
year 1974 at Philadelphia(200 cases), Winslow and Taylor  in the year 
1980 at Dallas (100 cases), Lean and Gregor in the year 1980 at London 
(317 cases), Dana et al in the year 1993 at Illinois (198 cases), Lindgrend 
et al in the year 1995 at Sweden(94 cases) of the incidence of vitreous 
hemorrhage shows spontaneous posterior vitreous detachment with or 
without retinal tear are found to be the first most common cause of 
vitreous hemorrhage in four studies and accounts for  38% of all cases. 
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B-Scan ultra sonography Shows Posterior Vitreous Detachment 
 
 
 
Optical Coherence Tomography shows incomplete  Posterior 
Vitreous Detachment 
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5. Retinal vein occlusion : 
It is the fifth most common cause of vitreous hemorrhage accounts 
4%(4 out of 100 cases) for all cases, the age incidence between 45 years 
to 63 years.75%( 3 out of 4 cases ) are males and 25%( 1 out of 4 cases ) 
are females . All patients studied were found to be hypertensive. The 
branch retinal vein occlusion accounts for75%(3 out of 4 cases ). The 
central retinal vein occlusion accounts for 25%( 1 out of 4 cases ). the 
incidence of vitreous hemorrhage in retinal vein occlusion associated 
with ocular pathology are as follows: 
Vitreous hemorrhage with PVD 25%( 1 out of 4 cases ) 
Vitreous hemorrhage without PVD 75%( 3 out of 4 cases ) 
In the past six retrospective studies (Morse et al in the year 1974 at 
Philadelphia (200 cases), Winslow and Taylor in the year 1980 at 
Dallas(100 cases), Lean and Gregor in the year 1980 at London (317 
cases), Dana et al in the year 1993 at Illianos (198 cases), Butner and 
Mecpherson in the year 1982at Lasvegas,(653 cases), Lindgrend et al in 
the year 1995 at Sweden (94 cases) of the incidence of vitreous 
hemorrhage it was found to be third or fourth single most common cause 
of vitreous hemorrhage, accounts for 11% of all cases, the mean age of 
incidence was 64 years and 88% were associated with hypertension. 
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Other causes of vitreous hemorrhage: 
The pars planitis, retinal vasculitis, Senile PVD, following post-
operative complications, unknown causes accounts for 16%( 16 out of 
100) of all cases. 
Supero Temporal Branch Retinal Vein Occlusion 
 
Central Retinal Vein Occlusion 
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SUMMARY 
The prospective study carried out on 100 patients who were all 
diagnosed as vitreous hemorrhage to analyse the various etiological 
incidence. The various etiologies of vitreus hemorrhage in this study are 
the following: proliferative diabetic retinopathy, ocular trauma, Eale’s 
disease, spontaneous PVD, Retinal vein occlusion, pars planitis, retinal 
vasculitis, senile PVD, post operative complication, and unknown. 
The total incidence of various etiologies wth respect to age, sex, 
involvement of the eye and associated ocular and systemic pathology 
were studied and recorded as follows: 
Total number of cases 100 
Age incidence between 22 to 78 Years 
Sex incidence Male  67 and Female  33 
DIAGNOSIS AGE (YRS) 
SEX 
M       F
LATERALITY
UNI      BI 
WITHOUT 
PVD 
WITH 
PVD RT RD TOTAL %
PDR 35 – 70 26     9 22       13 8 21 - 6 35 35
OCULAR TRAUMA 22 – 52 16    10 26         0 10 16 5 5 26 26
EALE’S DISEASE 22 – 58 8        3 6         5 8 3 - - 11 11
SPONTANEOUS 
PVD 62 – 70 7       1 8         0 - 3 4 1 8 8 
RETINAL VEIN 
OCCLUSION 45 – 63 3        1 4         0 3 1 - - 4 4 
PARS PLANITIS 34 – 46 1        1 2          0 2 - - - 2 2 
RETINAL 
VASCULITIS 44 – 58 0       2 2          0 2 - - - 2 2 
SENILE PVD 44 – 78 1        1 2          0 0 2 - - 2 2 
POST OP 
COMPLICATION 
(ECCE/PCIOL) 
65  -  68 1        1 2          0 2 - - - 2 2 
UNKNOWN 23 – 54 3        5 8          0 8 - - - 8 8 
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PROFORMA FOR THE STUDY OF VARIOUS ETIOLOGICAL 
INCIDENCE OF VITREOUS HAEMORRHAGE 
1. NAME  : 
2. AGE/SEX : 
3. IP NO : 
4. ADDRESS: 
5. OCCUPATION: 
6. CHIEF COMPLAINTS: 
A.OCULAR 
                                                                    RE                          LE                        
Duration 
a. Defective Vision (Distant/Near) 
b. Total loss of vision 
c. Floaters 
d. Flashes 
e. Pain  
f. Redness 
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Flashes of light : 
 Smoke signals : 
 Photophobia : 
 Perceptions of shadows and cobwebs : 
 Visual haze: 
 Others : 
 
B.SYSTEMIC-  
• Diabetes Mellitus. 
• Hyper tension. 
• Systemic Lupus Erythematosis. 
• Rhenumatoid Arthiritis. 
• Poly Arteritis Nodosa. 
• Dermatomyositis. 
• Bechet’s Disease. 
• Blood Disorders. 
  Thermbocytopenia 
  Leukemia 
  Hemophilia 
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  DIC 
  Anemia 
• Protein C Deficiency 
• Anticoagulant Therapy 
7. HISTORY: 
H/O – TRAUMA 
 Penetrating Ocular Injury. 
 Blunt Injury. 
 Perforating injury. 
Chest injury. 
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H/O – INFECTION 
BACTERIAL 
• Tuberculosis 
• Sysphilis 
• Others 
VIRAL 
• Cytomegalo virus 
• Human Immuno Deficiency 
• Others 
PROTOZOAL INFESTATION 
• Toxocara 
• Toxoplasma Gondi 
• Hydatid 
• Cysticercosis 
• Microfilaria 
H/O – OCULAR DISORDER 
• Eale’s Disease. 
• Posterior virteous detachment. 
• Retinal tear. 
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• Retinal detachment 
• Parsplanitis 
• Retinal vasculitis 
• Coat’s Disease 
• Central Retinal Artery Occlusion 
• Branch Retinal Artery Occlusion 
• Diabetic Retinopathy 
• Hypertension Retinopathy 
• Retinal Branch Artery Malformation 
• Retinal vein repture 
• Central retinal vein occlusion 
• Branch retinal vein occlusion 
• Persistant Hyaloid Artery  
• Prematurity Retinopathy 
• Arterio venous communication of retina 
H/O – TUMOUR 
• Retinal angioma 
• Choroidal malignant melanoma 
• Melanocytoma of the optic disc 
• Retinoblastoma 
• Retinal astrocytic hamartoma 
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• Carvernous haemangioma of the optic disc 
Duration: 
 
8. FAMILY HISTORY: 
 
9. PERSONAL HISTORY:  
Smoking/ Alcoholism/ Vegetarian/ Non Vegetarian 
10. TREATMENT HISTORY : 
                  Medications                                              Surgery 
 
 
11. EXAMINATION:                  RE                                          LE 
Visual Acuity 
Extra Ocular Examination 
Tension 
Lids 
Conjunctiva 
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Cornea 
Iris 
Anterior Chamber 
Pupil 
Lens 
Vitreous 
12. FUNDUS EXAMINATION:  
 
 
 
 
 
RE     LE 
 
DIRECT OPHTHALMOSCOPE  : 
INDIRECT OPHTHALMOSCOPE  : 
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SLIT LAMP EXAMINATION by the +90D lens. 
13. CLINICAL DIAGNOSIS : 
 
14. INVESTIGATIONS : 
a. Blood investigations:Total WBC count/Differential count/Erythrocyte 
sedimentation rate 
b. Investigations for collagen vascular disorders:  CRP, Serum 
Creatinine, Rheumatoid factor, Antinuclear antibodies.  
c. Blood sugar/Hba1c/BP 
d. PT 
e. aPTT                                                  
 
15. B SCAN: 
 
16. TREATMENT: 
 
17. FOLLOW UP: 
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CONCLUSION 
The various etiological incidence of vitreous hemorrhage depends 
on the study population and vary with mean age and sex of the patient 
and region where the study is performed. The study concludes that 
Proliferative diabetic retinopathy is the most common etiology 
because the incidence of the Diabetes mellitus is higher among the 
present population. 
Ocular trauma is the second most common cause of vitreous 
hemorrhage because the frequency of ocular injury is remarkably 
prevalent in our region and one of the leading causes of non congenital 
blindness in younger individual. 
Eale’s disease is the third most common cause of vitreous 
hemorrhage because the incidence of Eale’s disease is  1 in 250 of 
ophthalmic patients of Indian subcontinent. 
Spontaneous PVD is the fourth most common cause of vitreous 
hemorrhage. 
Retinal vein occlusion is fifth most common cause of vitreous 
hemorrhage. 
Other causes includes parsplanitis ,retinal vasculitis ,senile PVD, 
post operative complications and unknown causes. 
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In our study we managed the cases medically and 
surgically.medical management included  head end elevation, bed rest , 
control of systemic factors, pan retinal photocoagulation, and observation 
for three months.however it was noticed that these patients did not 
improve sidnificantly , and 27 %of the patients ,managed medically had 
persistent non clearing vitreous haemorrhage during the 3 rd visit. .these 
cases were taken up for surgical management in the form of 3 port 23 
guage PPV with vitreous haemorrhage aspiration± endo laser . The 
patients who underwent surgical management had a significant 
improvement in visual acuity during the first week of post-op follow up. 
Hence it was concluded that surgical management had better outcome in 
cases of non clearing vitreous haemorrhage. 
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MASTER CHART 
S.No Name Age Sex Eye V/A Diagnosis Etiology 
Associated 
Ocular 
pathology 
Associated 
Systemic 
diseases 
Medical Visual Acuity Surgery POST OP VA[BCVA] 
1 BALAN 54 M right eye HM Vitreous He UNKNOWN     observation 2/60     
2 SHANMUGAM 61 M right eye HM Vitreous He PDR PVD Type II   HM (non clearing) 
PPV/VH 
ASP/END LAS 6/18 
3 ARUN 24 M left eye HM Vitreous He EALE'S DIS   TB ATT/STER 2/60     
4 RAMESH 31 M right eye HM Vitreous He BLT INJ PVD   observation 3/60     
5 VICTOR 33 M left eye HM Vitreous He BLT INJ     observation 3/60     
6 VANITHA 24 F both eye HM Vitreous He EALE'S DIS   TB ATT/STER 2/60     
7 AROKIYAMMAL 65 F right eye HM Vitreous He PDR RD Type II   HM(non clearing) 
PPV/VH 
ASP/END LAS 6/24 
8 SORNAMBAL 62 F right eye HM Vitreous He PDR   Type II PRP 4/60     
9 MENAKA 48 F right eye HM Vitreous He BLT INJ PVD   observation 3/60     
10 RAVI 60 M left eye HM Vitreous He PDR PVD Type II   CFCF(Non clearing) 
PPV/VH 
ASP/END LAS 6/36 
11 RAJAN 55 M left eye HM Vitreous He PDR PVD Type II   HM(non clearing) 
PPV/VH 
ASP/END LAS 6/36 
12 SELVARAJ 49 M both eye PL Vitreous He PDR PVD Type I   HM(non clearing) 
PPV/VH 
ASP/END LAS 6/24 
13 NESAMANI 48 M right eye CFCF Vitreous He PDR RD Type I   
CFCF(non 
clearing) 
PPV/VH 
ASP/END LAS 6/24 
14 SAROJA 58 F right eye HM Vitreous He PDR PVD Type II   CFCF(non clearing) 
PPV/VH 
ASP/END LAS 6/36 
15 DEVAKI 63 F left eye HM Vitreous He PDR PVD Type II   HM(non clearing) 
PPV/VH 
ASP/END LAS 6/60 
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diseases 
Medical Visual Acuity Surgery POST OP VA[BCVA] 
16 PETER 35 M left eye HM Vitreous He PDR RD Type I   HM(non clearing) 
PPV/VH 
ASP/END LAS 5/60 
17 ABDUL 66 M left eye HM Vitreous He PDR PVD Type II   CFCF(non clearing) 
PPV/VH 
ASP/END LAS 6/60 
18 ANITHA 22 F right eye CFCF Vitreous He EALE'S DIS   TB ATT/STER 2/60     
19 GEETHA 26 F right eye CFCF Vitreous He EALE'S DIS   TB ATT/STER 3/60     
20 VIMALA 68 F left eye CFCF Vitreous He SPONT PVD PVD/RT   observation 4/60     
21 KUMAR 40 M right eye PL Vitreous He BLT INJ PVD   observation 4/60     
22 RAGAVAN 54 M right eye HM Vitreous He PDR   Type II   HM(non clearing) 
PPV/VH 
ASP/END LAS 6/60 
23 AMUDHAM 58 M both eye HM Vitreous He EALE'S DIS PVD TB ATT/STER 3/60     
24 RAJALAKSHMI 57 F left eye HM Vitreous He PDR   Type II PRP 4/60     
25 GANAPATHY 49 M left eye HM Vitreous He BLT INJ PVD   observation 2/60     
26 VELAN 60 M both eye HM Vitreous He PDR PVD Type II   HM(non clearing) 
PPV/VH 
ASP/END LAS 6/36 
27 SAMBANDAM 62 M right eye HM Vitreous He PDR PVD Type II   HM(non clearing) 
PPV/VH 
ASP/END LAS 6/24 
28 JAYARAM 66 M right eye HM Vitreous He SPONT PVD PVD/RT    observation 4/60     
29 MANNAR 63 M left eye HM Vitreous He PDR PVD Type II   CFCF(non clearing) 
PPV/VH 
ASP/END LAS 6/60 
30 SUNDARI 46 F right eye CFCF Vitreous He UNKNOWN     observation 4/60     
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31 MANOJ 25 M right eye CFCF Vitreous He BLT INJ PVD     
CFCF(non 
clearing) PPV/VH/SFIOL 5/60 
32 PERUMAL 53 M both eye PL Vitreous He EALE'S DIS PVD TB ATT/STER 2/60     
33 KOUSALYA 29 F right eye CFCF Vitreous He UNKNOWN     observation 4/60     
34 PALANI 46 M left eye HM Vitreous He BLT INJ PVD/RT   observation 3/60     
35 PANDIAN 62 M right eye HM Vitreous He SPONT PVD PVD/RT   observation 3/60     
36 SUKUMARAN 54 M left eye HM Vitreous He PDR PVD Type I observation CFCF(non clearing) 
PPV/VH 
ASP/END LAS 4/60 
37 RAMARAJAN 36 M right eye HM Vitreous He BLT INJ     observation 4/60     
38 KRISHNAKUMAR 38 M right eye HM Vitreous He BLT INJ PVD/RT   observation 4/60     
39 JOTHI 27 F left eye CFCF Vitreous He UNKNOWN     obervation 3/60     
40 VALI 26 F left eye CFCF Vitreous He BLT INJ PVD   observation 5/60     
41 SUBBIAH 64 M both eye HM Vitreous He PDR   Type II PRP 5/60     
42 POORNIMA 23 F right eye CFCF Vitreous He UNKNOWN     observation 3/60     
43 GANDHIRAJ 65 M left eye HM Vitreous He PDR PVD Type II   HM(non clearing) 
PPV/VH 
ASP/END LAS 6/18 
44 THANGAVEL 48 M right eye HM Vitreous He BLT INJ PVD/RT   observation 4/60     
45 ANAND BABU 50 M right eye HM Vitreous He PNT INJ RT/PVD   
Wound 
repair/observat
ion 
repair/observe
4/60     
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46 MALAR VIZHI 52 F left eye HM Vitreous He PER INJ PVD/RT   Wound repair/observe 4/60     
47 NALA PERUMAL 59 M both eye HM Vitreous He PDR PVD Type I PRP 5/60     
48 LOGANATHAN 63 M left eye HM Vitreous He PDR PVD Type II PRP 5/60     
49 KAMARAJ 60 M right eye HM Vitreous He PDR   Type II PRP 5/60     
50 RADHA 22 F left eye CFCF Vitreous He PNT INJ PVD/RT   
Wound 
repair/observe 2/60     
51 RAMASWAMY 49 M left eye PL Vitreous He BLT INJ PVD/RD   observation 4/60     
52 KATHIRAVAN 46 M right eye PL Vitreous He PNT INJ RD   Wound repair/observe 2/60     
53 SIVAKAMI 33 F right eye CFCF Vitreous He PNT INJ RT/PVD   
Wound 
repair/observe 2/60     
54 SRINIVASAN 35 M right eye CFCF Vitreous He BLT INJ PVD   observation 3/60     
55 DURAIRAJ 65 M left eye PL Vitreous He SPONT PVD PVD   observation 4/60     
56 MADHAVAN 68 M left eye CFCF Vitreous He SPONT PVD PVD/RT   observation 4/60     
57 UNNAMALAI 60 F left eye HM Vitreous He PDR PVD Type II   CFCF(non clearing) 
PPV/VH 
ASP/END LAS 6/24 
58 MUHAMADIN 60 M both eye HM Vitreous He PDR RD Type II   HM(non clearing) 
PPV/VH 
ASP/END LAS 6/36 
59 SUDHA 78 M left eye CFCF Vitreous He Senile PVD PVD   observation 2/60     
60 SANKARI 45 F right eye PL Vitreous He BRVO   HT systemic control 5/60     
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61 KAMESH 34 M left eye CFCF Vitreous He
PARS 
PLANITIS     STEROIDS 4/60     
62 PANKAJAM 62 F both eye HM Vitreous He PDR RD Type II   HM(non clearing) 
PPV/VH 
ASP/END LAS 6/60 
63 NAGESHWARI 60 F right eye HM Vitreous He PDR   Type II   HM(non clearing) 
PPV/VH 
ASP/END LAS 5/60 
64 VASANTHI 32 M left eye HM Vitreous He EALE'S DIS PVD TB ATT/STER 4/60     
65 INDRA 31 F left eye CFCF Vitreous He UNKNOWN     observation 3/60     
66 BABU 28 M left eye CFCF Vitreous He EALE'S DIS   TB ATT/STER 3/60     
67 SRIDHAR 62 M left eye HM Vitreous He SPONT PVD PVD   observation 3/60     
68 VIMALA 35 F right eye CFCF Vitreous He PNT INJ RT   
Wound 
rep/observatio
n 
2/60     
69 ANBARASI 46 F right eye HM Vitreous He PARS PLANITIS     STEROIDS 3/60     
70 UNNAMALAI 70 F both eye HM Vitreous He PDR PVD Type II   CFCF(non clearing) 
PPV/VH 
ASP/END LAS 6/36 
71 UDAYAN 59 M right eye PL Vitreous He CRVO PVD HT   1/60     
72 SELVAM 48 M left eye PL Vitreous He BLT INJ PVD/RD   observation 1/60     
73 HARIRAM 57 M right eye PL Vitreous He BRVO   HT Systemic control 5/60     
74 ANBARASI 58 F right eye PL Vitreous He RETINAL VAS     STEROIDS 4/60     
75 KUMARAESAN 46 M left eye HM Vitreous He BLT INJ PVD   observa 3/60     
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76 MUNNIYAPPAN 60 M both eye HM Vitreous He PDR   Type I PRP 5/60     
77 KOVALAN 63 M right eye HM Vitreous He BRVO   HT 
Systemic 
control/Observ
e 
5/60     
78 KAVITHA DEVI 65 F right eye HM Vitreous He POST OP     ECCE 2/60     
79 GOURILATHA 44 F left eye HM Vitreous He PNT INJ PVD/RD   
Wound 
repair/observat
ion 
repair/observat
ion 
3/60     
80 THAMARAI SELVI 44 F left eye HM Vitreous He RETINAL VAS     STEROIDS 3/60     
81 KARUPASAMY 44 M both eye HM Vitreous He PDR PVD Type II   CFCF(non clearing) 
PPV/VH 
ASP/END LAS 6/60 
82 MASILAMANI 68 M right eye HM Vitreous He POST OP     anti-VEGF 2/60     
83 THANIGAI 44 M right eye HM Vitreous He UNKNOWN     observation 3/60     
84 JAYAMANI 44 M both eye HM Vitreous He PDR PVD Type II   HM(non clearing0 
PPV/VH 
ASP/END LAS 5/60 
85 PONNUSAMY 44 M right eye HM Vitreous He UNKNOWN     observation 3/60     
86 GOPAL 64 M left eye HM Vitreous He SPON PVD/RD PVD   observation 3/60     
87 SUMITHA 44 F left eye CFCF Vitreous He Senile PVD PVD   observation 3/60     
88 FREDRICK 44 M right eye CFCF Vitreous He BLT INJ PVD/RT   observation 3/60     
89 BALASUNDARAM 44 M both eye HM Vitreous He PDR PVD Type II PRP 5/60     
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90 YAMUNA 44 F left eye CFCF Vitreous He PNT INJ PVD/RD   
Wound 
rep/observatio
n 
2/60     
91 PRIYA 44 F left eye CFCF Vitreous He BLT INJ PVD   observation 2/60     
92 MUTHAIAH 44 M both eye HM Vitreous He PDR PVD Type II PRP 5/60     
93 NANDHU 44 M both eye CFCF Vitreous He EALE'S DIS   TB  ATT/STER 3/60     
94 KANDAN 44 M left eye HM Vitreous He PDR   Type II   HM(non clearing) 
PPV/VH 
ASP/END LAS 6/24 
95 KANNAPAN 44 M left eye CFCF Vitreous He BLT INJ PVD/RT   observation 3/60  -   
96 VEDHA 70 M right eye HM Vitreous He SPONT PVD RD   observation 3/60  -   
97 RAJAPPA 44 M left eye PL Vitreous He PDR RD Type II   HM(non clearing) 
PPV/VH 
ASP/END LAS 6/60 
98 VIJAY 44 M both eye CFCF Vitreous He EALE'S DIS   TB ATT/STER 3/60  -   
99 VARADARAJAN 44 M both eye PL Vitreous He PDR PVD Type I   CFCF(non clearing) 
PPV/VH 
ASP/END LAS 6/36 
100 SIVA  44 M right eye CFCF Vitreous He EALE'S DIS   TB ATT/STER 3/60 -    
  
KEY TO MASTER CHART 
VH Vitreous hemorrhage 
PPV/VH ASAP/END LAS Pars plana vitrectomy with vitreous 
haemorrhage aspiration with endolaser 
ATT Anti tubercular treatment 
STER Steroids 
PRP Pan retinal photocoagulation 
BRVO Branch retinal vein occlusion 
CRVO Central retinal vein occlusion 
BLT INJ Blunt injury  
PER INJ Perforating injury 
PNT INJ Penetrating injury 
SPONT PVD Spontaneous posterior vitreous 
detachment 
PVD Posterior vitreous detachment 
RT Retinal tear 
RD Retinal detachment 
Anti-VEGF Anti vascular endothelial growth factor 
  
LIST OF SURGERIES  
 
S.No Name Age Sex Diagosis Etiology Surgery
1 SHANMUGAM 61 M Vitreous He PDR PPV/VH ASP/END LAS
2 AROKIYAMMAL 65 F Vitreous He PDR PPV/VH ASP/END LAS
3 RAVI 60 M Vitreous He PDR PPV/VH ASP/END LAS
4 RAJAN 55 M Vitreous He PDR PPV/VH ASP/END LAS
5 SELVARAJ 49 M Vitreous He PDR PPV/VH ASP/END LAS
6 NESAMANI 48 M Vitreous He PDR PPV/VH ASP/END LAS
7 SAROJA 58 F Vitreous He PDR PPV/VH ASP/END LAS
8 DEVAKI 63 F Vitreous He PDR PPV/VH ASP/END LAS
9 PETER 35 M Vitreous He PDR PPV/VH ASP/END LAS
10 ABDUL 66 M Vitreous He PDR PPV/VH ASP/END LAS
11 RAGAVAN 54 M Vitreous He PDR PPV/VH ASP/END LAS
12 VELAN 60 M Vitreous He PDR PPV/VH ASP/END LAS
13 SAMBANDAM 62 M Vitreous He PDR PPV/VH ASP/END LAS
14 MANNAR 63 M Vitreous He PDR PPV/VH ASP/END LAS
15 MANOJ 25 M Vitreous He BLT INJ PPV/VH/SFIOL
16 SUKUMARAN 54 M Vitreous He PDR PPV/VH ASP/END LAS
17 GANDHIRAJ 65 M Vitreous He PDR PPV/VH ASP/END LAS
18 UNNAMALAI 60 F Vitreous He PDR PPV/VH ASP/END LAS
19 MUHAMADIN 60 M Vitreous He PDR PPV/VH ASP/END LAS
20 PANKAJAM 62 F Vitreous He PDR PPV/VH ASP/END LAS
21 NAGESHWARI 60 F Vitreous He PDR PPV/VH ASP/END LAS
22 UNNAMALAI 70 F Vitreous He PDR PPV/VH ASP/END LAS
23 KARUPASAMY 44 M Vitreous He PDR PPV/VH ASP/END LAS
24 JAYAMANI 44 M Vitreous He PDR PPV/VH ASP/END LAS
25 KANDAN 44 M Vitreous He PDR PPV/VH ASP/END LAS
26 RAJAPPA 44 M Vitreous He PDR PPV/VH ASP/END LAS
27 VARADARAJAN 44 M Vitreous He PDR PPV/VH ASP/END LAS
